Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Ideaya Biosciences Inc (NASDAQ: IDYA) closed at $25.92 up 0.70% from its previous closing price of $25.74. In other words, the price has increased by $0.70 from its previous closing price. On the day, 1.38 million shares were traded. IDYA stock price reached its highest trading level at $26.6 during the session, while it also had its lowest trading level at $25.555.
Ratios:
For a deeper understanding of Ideaya Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.39 and its Current Ratio is at 12.39. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Guggenheim on September 18, 2025, initiated with a Buy rating and assigned the stock a target price of $50.
On September 04, 2025, Citizens JMP started tracking the stock assigning a Mkt Outperform rating and target price of $41. On September 04, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $40.Barclays initiated its Overweight rating on September 04, 2025, with a $40 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDYA now has a Market Capitalization of 2271724288 and an Enterprise Value of 1628583296. For the stock, the TTM Price-to-Sale (P/S) ratio is 324.53 while its Price-to-Book (P/B) ratio in mrq is 2.37. Its current Enterprise Value per Revenue stands at 232.655 whereas that against EBITDA is -4.266.
Stock Price History:
The Beta on a monthly basis for IDYA is 0.13, which has changed by -0.17373288 over the last 52 weeks, in comparison to a change of 0.1675967 over the same period for the S&P500. Over the past 52 weeks, IDYA has reached a high of $36.64, while it has fallen to a 52-week low of $13.45. The 50-Day Moving Average of the stock is 6.81%, while the 200-Day Moving Average is calculated to be 18.33%.
Shares Statistics:
For the past three months, IDYA has traded an average of 1.10M shares per day and 1275700 over the past ten days. A total of 87.64M shares are outstanding, with a floating share count of 80.64M. Insiders hold about 8.00% of the company’s shares, while institutions hold 104.12% stake in the company. Shares short for IDYA as of 1756425600 were 10088795 with a Short Ratio of 9.19, compared to 1753920000 on 10120270. Therefore, it implies a Short% of Shares Outstanding of 10088795 and a Short% of Float of 13.58.
Earnings Estimates
The stock of Ideaya Biosciences Inc (IDYA) is currently drawing attention from 15.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.87, with high estimates of -$0.61 and low estimates of -$1.03.
Analysts are recommending an EPS of between -$0.98 and -$3.67 for the fiscal current year, implying an average EPS of -$3.1. EPS for the following year is -$3.33, with 16.0 analysts recommending between -$2.4 and -$4.11.
